Accessibility to Oral Antiviral Therapy for Patients with Chronic Hepatitis C in the United States.
作者: Saab SammyJimenez MelissaFong TiffanyWu CrystalBau SheronaJamal ZohaGrotts JonathanElashoff David
作者单位: 1Department of Medicine, University of California, Los Angeles, CA, USA; Department of Surgery, University of California, Los Angeles, CA, USA.
2Department of Surgery, University of California, Los Angeles, CA, USA.
刊名: Journal of clinical and translational hepatology, 2016, Vol.4 (2), pp.76-82
来源数据库: PubMed Journal
DOI: 10.14218/JCTH.2016.00011
关键词: Antiviral therapyHealthcare accessHepatitis C
原始语种摘要: Background : Hepatitis C (HCV) direct acting antiviral agents (DAAs) are safe, effective, and tolerable. Most contraindications to interferon-based treatment are no long applicable. The aims of this study were to understand the predictors of approval to drug accessibility. Methods : We studied all consecutive patients with HCV prescribed DAAs between October 2014 and July 2015. Data on demographic, socio-economic status, comorbidities, baseline laboratory values, and assessment of liver disease severity, insurance, and specialty pharmacy type were collected. Multivariate analyses were performed to identify predictors of prescription approval. Results : In total, 410 patients were prescribed DAAs between October 2014 and July 2015. Of those, 332 (81%) patients were insurance approved for...
全文获取路径: PubMed  (合作)
分享到:

×
关键词翻译
关键词翻译
  • insurance 保险
  • approved 认可的
  • employment 雇用
  • multivariate 多元
  • income 收入
  • approval 赞成
  • economic 经济的
  • October 十月
  • liver 
  • advanced 先进的